NASDAQ: ISPC
Ispecimen Inc Stock Ownership - Who owns Ispecimen?

Insider buying vs selling

Have Ispecimen Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ISPC insiders and whales buy or sell their stock.

ISPC Shareholders

What type of owners hold Ispecimen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew L. Ross532.85%3,951,388$20.90MInsider
George H. Scholl113.96%845,106$4.47MInsider
Obf Investments LLC113.54%841,981$4.45MInsider
Christopher Ianelli57.36%425,359$2.25MInsider
Jill Mullan33.20%246,226$1.30MInsider
Benjamin Bielak11.37%84,348$446.20kInsider
Tracy Curley6.68%49,541$262.07kInsider
Geode Capital Management LLC5.61%41,594$220.03kInstitution
Vanguard Group Inc3.97%29,407$155.56kInstitution
Susquehanna International Group LLP2.03%15,063$79.68kInstitution

1 of 3

ISPC vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ISPC1.92%98.08%
QUCY9.20%14.59%Net Buying
BNBX2.37%97.63%
NDRA5.33%94.67%Net Buying
ADVB4.08%0.00%

Ispecimen Stock Ownership FAQ

Who owns Ispecimen?

Ispecimen (NASDAQ: ISPC) is owned by 17.08% institutional shareholders, 870.70% Ispecimen insiders, and 0.00% retail investors. Andrew L. Ross is the largest individual Ispecimen shareholder, owning 3.95M shares representing 532.85% of the company. Andrew L. Ross's Ispecimen shares are currently valued at $20.23M.

If you're new to stock investing, here's how to buy Ispecimen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.